Hormonotherapy of meningiomas with medroxyprogesterone acetate
Authors:
- Heinz A. GerberHGHeinz A. Gerber
- Ernst WaeltiEWErnst Waelti
- Thomas SchaffnerTSThomas Schaffner
- Regula V. MarkwalderRMRegula V. Markwalder
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Surgical Neurology
- Vol. 30 (2) , 97-101
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosolsSurgical Neurology, 1987
- Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumorsJournal of Neurosurgery, 1986
- Production and characterization of monoclonal antibodies against human neuroblastomaInternational Journal of Cancer, 1986
- Antiestrogenic therapy of meningiomas—a pilot studySurgical Neurology, 1985
- Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomasJournal of Neurosurgery, 1985
- Biological Expression of Steroid Hormone Receptors in Primary Meningioma Cells in Monolayer CultureClinical Neuropharmacology, 1984
- Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic featuresSurgical Neurology, 1983
- Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosolsEuropean Journal of Cancer and Clinical Oncology, 1983
- A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1982
- Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancerEuropean Journal of Cancer (1965), 1979